The rapid emergence of the Chinese biotech industry has panicked U.S. politicians, but investors and patients caution that a clampdown on pharmaceutical collaboration could hurt everyone.
The rapid emergence of the Chinese biotech industry has panicked U.S. politicians, but investors and patients caution that a clampdown on pharmaceutical collaboration could hurt everyone.
<iframe src="https://statesidedaily.com/embed/cluster/f4ceddecdb063fd3eb1aacad4846420ba81e047a" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="As Politicians Argue About China, US Patients Find Cutting-Edge Treatment There"></iframe>
